Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes
- PMID: 23396458
Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes
Abstract
Objective: To examine involvement of oxidative stress in the pathogenesis and vascular complications of diabetes.
Methods: This cross sectional study was conducted at the Joint Laboratory Office (JLO), Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan from April 2010 to December 2011. Fasting glucose, glycosylated hemoglobin (HbA1c), serum lipids, urinary albumin excretion (UAE), ankle brachial index and pulse wave velocity were measured in 51 patients with type 2 diabetes and 20 healthy controls. The fundus oculi and Achilles` tendon reflex were also examined in the patients. Oxidative stress was measured by a reactive oxygen metabolites (ROM) test and antioxidant potency was evaluated by a biological antioxidant potential (BAP) test in the Free Radical Analytical System (FRAS)-4. Superoxide dismutase (SOD) activity was assayed using electron spin resonance (ESR).
Results: Diabetic patients tended to have increased ROM compared with healthy subjects, and ROM showed a marked increase with progression of diabetic retinopathy. A significant reduction of BAP was found in patients who were smokers, and BAP was significantly negatively correlated with UAE (p=0.029). Serum SOD activity significantly decreased with progression of diabetic retinopathy (p=0.017).
Conclusion: The FRAS-4 measurements showed that increased oxidative stress and decreased antioxidative potency are linked to deteriorated blood glucose control, heavy smoking, and progression of retinopathy and nephropathy in patients with type 2 diabetes.
Similar articles
-
Oxidative stress and its association with TNF-α-308 G/C and IL-1α-889 C/T gene polymorphisms in patients with diabetes and diabetic nephropathy.Gene. 2015 May 15;562(2):197-202. doi: 10.1016/j.gene.2015.02.069. Epub 2015 Feb 27. Gene. 2015. PMID: 25732517
-
Lipid peroxidation and antioxidant status in patients with diabetic retinopathy.Indian J Physiol Pharmacol. 2005 Apr;49(2):187-92. Indian J Physiol Pharmacol. 2005. PMID: 16170987
-
The oxidative stress status in diabetes mellitus and diabetic nephropathy.Acta Diabetol. 2010 Dec;47 Suppl 1:71-6. doi: 10.1007/s00592-009-0128-1. Epub 2009 May 28. Acta Diabetol. 2010. PMID: 19475334
-
Role of oxidative stress in diabetes-induced complications and their management with antioxidants.Arch Physiol Biochem. 2024 Dec;130(6):616-641. doi: 10.1080/13813455.2023.2243651. Epub 2023 Aug 11. Arch Physiol Biochem. 2024. PMID: 37571852 Review.
-
The retina: oxidative stress and diabetes.Redox Rep. 2003;8(4):187-92. doi: 10.1179/135100003225002673. Redox Rep. 2003. PMID: 14599341 Review.
Cited by
-
The evolving role of long noncoding RNA HIF1A-AS2 in diabetic retinopathy: a cross-link axis between hypoxia, oxidative stress and angiogenesis via MAPK/VEGF-dependent pathway.Redox Rep. 2022 Dec;27(1):70-78. doi: 10.1080/13510002.2022.2050086. Redox Rep. 2022. PMID: 35285425 Free PMC article.
-
The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress.PLoS One. 2015 Nov 10;10(11):e0142571. doi: 10.1371/journal.pone.0142571. eCollection 2015. PLoS One. 2015. PMID: 26554379 Free PMC article.
-
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A Review.Antioxidants (Basel). 2022 Aug 9;11(8):1541. doi: 10.3390/antiox11081541. Antioxidants (Basel). 2022. PMID: 36009260 Free PMC article. Review.
-
Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy.Saudi J Ophthalmol. 2018 Oct-Dec;32(4):318-323. doi: 10.1016/j.sjopt.2018.05.002. Epub 2018 May 29. Saudi J Ophthalmol. 2018. PMID: 30581303 Free PMC article. Review.
-
Oxidative stress and diabetic retinopathy: development and treatment.Eye (Lond). 2017 Aug;31(8):1122-1130. doi: 10.1038/eye.2017.64. Epub 2017 Apr 28. Eye (Lond). 2017. PMID: 28452994 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous